DrugPatentWatch Database Preview
Details for Patent: 7,659,256
Which drugs does patent 7,659,256 protect, and when does it expire?
This patent has twenty-two patent family members in ten countries.
Summary for Patent: 7,659,256
Title: | Combination therapy for effecting weight loss and treating obesity |
Abstract: | The present invention features a novel therapy for effecting weight loss which involves treating a subject with a sympathomimetic agent (e.g., phentermine or a phentermine-like drug) in combination with an anticonvulsant sulfamate derivative (e.g., topiramate) such that the subject experiences weight loss. The combination methods of the present invention also are effective against symptoms associated with Syndrome X. The invention also features pharmaceutical compositions and kits for use in the practice of these novel therapies. |
Inventor(s): | Najarian; Thomas (Los Osos, CA) |
Assignee: | Vivus, Inc. (Mountain View, CA) |
Application Number: | 11/385,199 |
Patent Claim Types: see list of patent claims | Use; Formulation; Dosage form; Delivery; Composition; |
Drugs Protected by US Patent 7,659,256
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Patent Submitted |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Vivus | QSYMIA | phentermine hydrochloride; topiramate | CAPSULE, EXTENDED RELEASE;ORAL | 022580-001 | Jul 17, 2012 | RX | Yes | No | ➤ Try a Free Trial | ➤ Try a Free Trial | Y | USE OF QSYMIA (PHENTERMINE AND TOPIRAMATE) FOR WEIGHT MANAGEMENT, INCLUDING, BUT NOT LIMITED TO EFFECTING WEIGHT LOSS, TREATING OBESITY, AND/OR TREATING OVERWEIGHT | ➤ Try a Free Trial | |||
Vivus | QSYMIA | phentermine hydrochloride; topiramate | CAPSULE, EXTENDED RELEASE;ORAL | 022580-002 | Jul 17, 2012 | RX | Yes | No | ➤ Try a Free Trial | ➤ Try a Free Trial | Y | USE OF QSYMIA (PHENTERMINE AND TOPIRAMATE) FOR WEIGHT MANAGEMENT, INCLUDING, BUT NOT LIMITED TO EFFECTING WEIGHT LOSS, TREATING OBESITY, AND/OR TREATING OVERWEIGHT | ➤ Try a Free Trial | |||
Vivus | QSYMIA | phentermine hydrochloride; topiramate | CAPSULE, EXTENDED RELEASE;ORAL | 022580-003 | Jul 17, 2012 | RX | Yes | No | ➤ Try a Free Trial | ➤ Try a Free Trial | Y | USE OF QSYMIA (PHENTERMINE AND TOPIRAMATE) FOR WEIGHT MANAGEMENT, INCLUDING, BUT NOT LIMITED TO EFFECTING WEIGHT LOSS, TREATING OBESITY, AND/OR TREATING OVERWEIGHT | ➤ Try a Free Trial | |||
Vivus | QSYMIA | phentermine hydrochloride; topiramate | CAPSULE, EXTENDED RELEASE;ORAL | 022580-004 | Jul 17, 2012 | RX | Yes | Yes | ➤ Try a Free Trial | ➤ Try a Free Trial | Y | USE OF QSYMIA (PHENTERMINE AND TOPIRAMATE) FOR WEIGHT MANAGEMENT, INCLUDING, BUT NOT LIMITED TO EFFECTING WEIGHT LOSS, TREATING OBESITY, AND/OR TREATING OVERWEIGHT | ➤ Try a Free Trial | |||
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Patent Submitted |
Non-Orange Book US Patents Family Members for Patent 7,659,256
For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.
The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.
Patent No. | Title | Estimated Patent Expiration |
---|---|---|
7,674,776 | Combination therapy for effecting weight loss and treating obesity | ➤ Try a Free Trial |
8,802,636 | Combination therapy for treatment of sleep apnea | ➤ Try a Free Trial |
7,056,890 | Combination therapy for effecting weight loss and treating obesity | ➤ Try a Free Trial |
7,553,818 | Combination therapy for effecting weight loss and treating obesity | ➤ Try a Free Trial |
Patent No. | Title | Estimated Patent Expiration |
International Patents Family Members for US Patent 7,659,256
Country | Document Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Austria | 369126 | ➤ Try a Free Trial | |||
Australia | 2008262566 | ➤ Try a Free Trial | |||
Australia | 5489600 | ➤ Try a Free Trial | |||
Australia | 770068 | ➤ Try a Free Trial | |||
Country | Document Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |